Recordati Industria Chimica e Farmaceutica S.p.A. (RICFY PINK) stock market data APIs

$14.41 0(0%)
as of January 21, 2025

Recordati Industria Chimica e Farmaceutica S.p.A. Financial Data Overview

Price chart is built with Anychart

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceuticals in Italy and internationally. It operates through Specialty and Primary Care and Rare Diseases segments. The company's product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS for the treatment of cystine crystal deposits in the cornea. It also develops CARBAGLU for hyperammonemia due to NAGS deficiency; QARZIBA, an apeiron for the treatment of high-risk neuroblastoma patients with a partial response at the chemotherapeutical through myeloablative therapy and stem cell transplantation, and relapsed or refractory neuroblastoma; and FOTIVDA, an oral inhibitor first-line treatment of renal cell carcinoma. In addition, the company offers SYLVANT for the treatment of idiopathic multicentric castleman diseases; REAGILA for Schizophrenia; and ELIGARD for hormone-dependent prostate cancer, as well as CAPHOSOL, a medical device for treatment electrolyte supersaturated of oral mucositis due to chemo and radiation therapy. Recordati Industria Chimica e Farmaceutica S.p.A. was founded in 1926 and is headquartered in Milan, Italy. Recordati Industria Chimica e Farmaceutica S.p.A. is a subsidiary of Rossini S.à R.L.

Prev. Close 14.41
Open 14.41
Volume 455
High 14.41
Low 14.41
52 wk Range 10.2749-15.8112
Market Cap 11 888 M
P/E Ratio 27.1887
Shares Outstanding 825 M
Revenue 2 269 M
EPS 0.1483
Dividends (Yield) 0.0219
Beta 0.398

Why to choose EODHD?

Prices start at $19.99

24/7 Live support

Robust, powerful and reliable data

API Simplicity of a few lines of code


Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW

Get Recordati Industria Chimica e Farmaceutica S.p.A. data using free add-ons & libraries


Get Recordati Industria Chimica e Farmaceutica S.p.A. Fundamental Data

Recordati Industria Chimica e Farmaceutica S.p.A. Fundamental data includes:

  • Net Revenue: 2 269 M
  • EBITDA: 837 M
  • Earnings Per Share: 0
  • Income Statements
  • Balance Sheets
  • Cash flows

Plans with Fundamental data

Starting from

$ 59.99 /mo.
COMPARE PLANS

End-of-day & Earnings data

Get Recordati Industria Chimica e Farmaceutica S.p.A. Earnings data

Calendar & News package for

$ 19.99 /mo.

What’s included:

  • Latest Release: 2024-11-08
  • EPS/Forecast: NaN
GET THE PACKAGE

Get Recordati Industria Chimica e Farmaceutica S.p.A. End-of-day data

EOD Historical Data package for

$ 19.99 /mo.

What’s included:

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
GET THE PACKAGE
Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW
  • Flexibility: No long-term commitments, just a minimum of one month
  • Instant access: Get your API key and instructions within seconds of subscribing
  • Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.

What’s included:

  • API Calls per Day: 100 000/day
  • API Requests per Min.: 1000/minute
  • Type of Usage: Personal use

Data access:

Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.

GET THE PACKAGE
Chat